Larimar Therapeutics, Inc.
← Back to LRMR Overview

Larimar Therapeutics, Inc. (LRMR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.21

Financial Fundamentals

LRMRQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-06-30-20.89
2014-09-30-9.11
2014-12-31
2015-03-31-22.59
2015-06-30-15.81
2015-09-30-13.08
2015-12-31-2.18
2016-03-31-3.08
2016-06-30-3.26
2016-09-30-1.85
2016-12-31-2.50
2017-03-31-2.94
2017-06-30-2.16
2017-09-30-2.31
2017-12-31-2.91
2018-03-31-3.86
2018-06-30-5.37
2018-09-30-8.24
2018-12-31-3.29
2019-03-31-5660.00
2019-06-30-8.77
2019-09-30-2.36
2019-12-31-5.05
2020-03-31-3.21
2020-06-30-2.65
2020-09-30-5.93
2020-12-31-6.01
2021-03-31-4.81
2021-06-30-3.11
2021-09-30-3.13
2021-12-31-5.39
2022-03-31-2.07
2022-06-30-1.04
2022-09-30-2.16
2022-12-31-2.95
2023-03-31-9.44
2023-06-30-4.12
2023-09-30-4.70
2023-12-31-3.79
2024-03-31-6.91
2024-06-30-6.06
2024-09-30-6.82
2024-12-31-2.15
2025-03-31-1.17
2025-06-30-1.76
2025-09-30-1.32
2025-12-31-1.30
2026-03-31-3.21

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.